Transoral Robotic Surgical Resection Followed by Randomization to Low- or Standard-Dose IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer: ECOG-ACRIN 3311 Trial
By
Yale Cancer Center
FEATURING
Saral Mehra
By
Yale Cancer Center
FEATURING
Saral Mehra
Login to view comments.
Click here to Login